• Issue

    Journal of the European Academy of Dermatology and Venereology: Volume 36, Issue 6

    757-933, e399-e496
    June 2022
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Issue Information

Free Access

Issue Information

  • Pages: 757-762
  • First Published: 10 May 2022

EDITOR'S PICKS

Free Access

Editor's Picks

  • Page: 763
  • First Published: 10 May 2022

COMMENTARIES

Free Access

Genetic markers for methazolamide-induced Stevens–Johnson syndrome and toxic epidermal necrolysis

Po-Wei Huang,  Chia-Yu Chu, 
  • Page: 764
  • First Published: 10 May 2022

Linked article: M. Jiang et al. J Eur Acad Dermatol Venereol 2022; 36: 873–880. https://doi.org/10.1111/jdv.17980.

Open Access

Genetic understanding of vascular anomalies: better classification and risk-stratification with targeted therapeutic options – a new horizon for vascular anomaly patients

C.J.M. van der Vleuten, 
  • Pages: 765-766
  • First Published: 10 May 2022

Linked article: F.N. El Sissy et al. J Eur Acad Dermatol Venereol 2022; 36: 905–912. https://doi.org/10.1111/jdv.18046.

Free Access

Commentary to ‘Development of a patient-reported experience measure for chronic inflammatory skin diseases’ by E. Van den Steen et al.

A.-H. Fink-Wagner, 
  • Pages: 767-768
  • First Published: 10 May 2022

Linked article: E. Van den Steen et al. J Eur Acad Dermatol Venereol 2022; 36: 913–921. https://doi.org/10.1111/jdv.17982.

HISTORICAL PERSPECTIVES

Open Access

Pioneers in Dermatology and Venereology: an Interview with Professor Beatrix Volc-Platzer

B. Volc-Platzer, 
  • Pages: 769-771
  • First Published: 10 May 2022

GUIDELINES AND POSITION STATEMENTS

Free Access

2021 international consensus statement on optical coherence tomography for basal cell carcinoma: image characteristics, terminology and educational needs

C.S.K. Fuchs,  V.K. Ortner,  M. Mogensen,  A.M. Rossi,  G. Pellacani,  J. Welzel,  K. Mosterd,  P. Guitera,  L.J. Nayahangan,  V.L. Johnsson,  M. Haedersdal,  M.G. Tolsgaard,  OCT-BCC expert panel , 
  • Pages: 772-778
  • First Published: 09 February 2022

REVIEW ARTICLES

Open Access

The use of lasers in vitiligo, an overview

N.F. Post,  N. Ezekwe,  V.S. Narayan,  M.W. Bekkenk,  N. Van Geel,  I. Hamzavi,  T. Passeron,  A. Wolkerstorfer, 
  • Pages: 779-789
  • First Published: 17 February 2022

Scalp dysesthesia: a neuropathic phenomenon

T. Ju,  A. Vander Does,  G. Yosipovitch, 
  • Pages: 790-796
  • First Published: 05 February 2022
Open Access

Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis

J.J. Wu,  A. Kavanaugh,  M.G. Lebwohl,  R. Gniadecki,  J.F. Merola, 
  • Pages: 797-806
  • First Published: 02 March 2022
Open Access

Classifying atopic dermatitis: a systematic review of phenotypes and associated characteristics

A.L. Bosma,  A. Ascott,  R. Iskandar,  K. Farquhar,  J. Matthewman,  M.W. Langendam,  A. Mulick,  K. Abuabara,  H.C. Williams,  P.I. Spuls,  S.M. Langan,  M.A. Middelkamp-Hup, 
  • Pages: 807-819
  • First Published: 16 February 2022

Dupilumab ocular side effects in patients with atopic dermatitis: a systematic review

N. Neagu,  C. Dianzani,  G. Avallone,  C. Dell’Aquila,  S.-H. Morariu,  I. Zalaudek,  C. Conforti, 
  • Pages: 820-835
  • First Published: 04 February 2022

ORIGINAL ARTICLES AND SHORT REPORTS ONCOLOGY

No evidence of Borrelia in cutaneous infiltrates of B-cell lymphomas with a highly sensitive, semi-nested real-time polymerase chain reaction targeting the 5S-23S intergenic spacer region

K. Papadopoulou,  T.M. Falk,  D. Metze,  A. Böer-Auer, 
  • Pages: 836-845
  • First Published: 16 February 2022

Outcome of cutaneous squamous cell carcinoma with microscopic residual disease after surgery and usefulness of postoperative radiotherapy: a retrospective cohort study

L. Revelles-Peñas,  D. Revilla-Nebreda,  S. Becerril,  L.A. Corchete,  I. Domínguez-Rullán,  M. Martins-Lopes,  P. Arias-Rodríguez,  A. Rodríguez-Guitiérrez,  L.A. Pérez-Romansanta,  C. Román-Curto,  J. Cañueto, 
  • Pages: 846-854
  • First Published: 28 February 2022

PSORIASIS

Open Access

Long-term, durable, absolute Psoriasis Area and Severity Index and health-related quality of life improvements with risankizumab treatment: a post hoc integrated analysis of patients with moderate-to-severe plaque psoriasis

M. Gooderham,  A. Pinter,  L.K. Ferris,  R.B. Warren,  T. Zhan,  J. Zeng,  A.M. Soliman,  C. Kaufmann,  B. Kaplan,  H. Photowala,  B. Strober, 
  • Pages: 855-865
  • First Published: 16 February 2022

ALLERGY AND ECZEMA

Open Access

Is benzyl alcohol a significant contact sensitizer?

J. Geier,  B. Ballmer-Weber,  T. Buhl,  J. Rieker-Schwienbacher,  V. Mahler,  H. Dickel,  S. Schubert,  for the IVDK , 
  • Pages: 866-872
  • First Published: 26 January 2022

Unique motif shared by HLA-B*59:01 and HLA-B*55:02 is associated with methazolamide-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Han Chinese

M. Jiang,  F. Yang,  L. Zhang,  D. Xu,  Y. Jia,  Y. Cheng,  S. Han,  T. Wang,  Z. Chen,  Y. Su,  Z. Zhu,  S. Chen,  J. Zhang,  L. Wang,  L. Yang,  J. Yang,  X. Luo,  Q. Xing, 
  • Pages: 873-880
  • First Published: 05 February 2022

Linked Commentary: P.-W. Huang and C.-Y. Chu. J Eur Acad Dermatol Venereol 2022; 36: 764. https://doi.org/10.1111/jdv.18158.

SKIN INFECTIOLOGY, VENEREOLOGY AND SEXUAL HEALTH

Open Access

Influence of dietary supplementation of short-chain fatty acid sodium propionate in people living with HIV (PLHIV)

V. Brauckmann,  S. Nambiar,  A. Potthoff,  S. Höxtermann,  J. Wach,  A. Kayser,  C. Tiemann,  A.K. Schuppe,  N.H. Brockmeyer,  A. Skaletz-Rorowski, 
  • Pages: 881-889
  • First Published: 17 February 2022

ACNE, ROSACEA AND HIDRADENITIS SUPPURATIVA

Incidence, prevalence and risk of acne in adolescent and adult patients with atopic dermatitis: a matched cohort study

Jacob P. Thyssen,  Lea K. Nymand,  Julia-Tatjana Maul,  Peter Schmid-Grendelmeier,  Jashin J. Wu,  Simon Francis Thomsen,  Alexander Egeberg, 
  • Pages: 890-896
  • First Published: 26 February 2022

TRASS: a global approach to assess the severity of truncal acne

N. Auffret,  J.M. Nguyen,  M.-T. Leccia,  J.P. Claudel,  B. Dréno, 
  • Pages: 897-904
  • First Published: 16 February 2022

GENETICS

Somatic mutational landscape of extracranial arteriovenous malformations and phenotypic correlations

F.N. El Sissy,  M. Wassef,  B. Faucon,  D. Salvan,  S. Nadaud,  F. Coulet,  H. Adle-Biassette,  F. Soubrier,  A. Bisdorff,  M. Eyries, 
  • Pages: 905-912
  • First Published: 02 March 2022

Linked Commentary: C.J.M. van der Vleuten. J Eur Acad Dermatol Venereol 2022; 36: 765–766. https://doi.org/10.1111/jdv.18155.

QUALITY OF LIFE

Open Access

Development of a patient-reported experience measure for chronic inflammatory skin diseases

E. Van den Steen,  D. Ramaekers,  M. Horlait,  J. Gutermuth, 
  • Pages: 913-921
  • First Published: 04 February 2022

Linked Commentary: A.-H. Fink-Wagner. J Eur Acad Dermatol Venereol 2022; 36: 767–768. https://doi.org/10.1111/jdv.18153.

PHOTODERMATOLOGY

Open Access

A new in vitro method to predict in vivo photoprotection of skin hyperpigmentation induced by visible light

L. Duteil,  B. Cadars,  C. Queille-Roussel,  I. Giraud,  F. Drulhon,  C. Graizeau,  A. Guyoux,  T. Passeron, 
  • Pages: 922-926
  • First Published: 28 February 2022

DERMATOSUSRGERY

Postoperative surgical site infection rate in patients with diabetes following Mohs micrographic surgery: a retrospective analysis

T. Hansen,  A. Gangal,  E. Hijab,  D. Barrett,  H. Yeung,  Y. Cao,  J. Switchenko,  T.W. Blalock, 
  • Pages: 927-931
  • First Published: 05 February 2022

ANNOUNCEMENTS

Announcement

  • Page: 932
  • First Published: 10 May 2022

Announcement

  • Page: 933
  • First Published: 10 May 2022

COVID-19 SPECIAL FORUM

Cutaneous arteritis following mRNA-1273 Moderna COVID-19 vaccination

T. Ogawa,  U. Aitake,  T. Nomura, 
  • Pages: e399-e400
  • First Published: 23 January 2022

A first case of ‘Covid toes’ from a viral vector-based COVID-19 vaccine

A. Van Loon,  D. Mortelmans,  V. Siozopoulou,  B. Ogunjimi,  H. Jansens,  J. Lambert,  O. Aerts, 
  • Pages: e400-e402
  • First Published: 23 January 2022

A study of COVID-19 vaccine (Covishield) induced dermatological adverse effects from India

P. Das,  S. Arora,  G.K. Singh,  P. Bellad,  R. Rahman,  A. Bahuguna,  D. Sapra,  R. Shrivastav,  A. Gupta, 
  • Pages: e402-e404
  • First Published: 24 January 2022

Eruptive pyogenic granulomas following coronavirus disease 2019

C.A. Maronese,  C. Moltrasio,  D.A. Marletta,  G. Genovese,  A.V. Marzano, 
  • Pages: e404-e406
  • First Published: 24 January 2022

Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccination

W.-K. Hung,  C.-C. Chi, 
  • Pages: e407-e409
  • First Published: 24 January 2022

Atopic dermatitis exacerbation after Covid-19 vaccination in Dupilumab-treated patients

L. Potestio,  M. Napolitano,  L. Bennardo,  G. Fabbrocini,  C. Patruno, 
  • Pages: e409-e411
  • First Published: 23 January 2022

Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centre

D. Koumaki,  S.-E. Krueger-Krasagakis,  M. Papadakis,  A.C. Katoulis,  I. Gkiaouraki,  K. Zografaki,  D. Mylonakis,  K. Krasagakis, 
  • Pages: e411-e415
  • First Published: 24 January 2022

Estimating the incidence of COVID-19 skin manifestations on the general population in a territorial setting

C. Zengarini,  A. Guglielmo,  M. Giovani,  C. Preci,  E. Dika,  B.M. Piraccini,  A. Pileri, 
  • Pages: e415-e417
  • First Published: 26 January 2022

Stevens-Johnson syndrome induced by Vaxvetria (AZD1222) COVID-19 vaccine

C. Aimo,  E.B. Mariotti,  A. Corrà,  E. Cipollini,  O. Le Rose,  C. Serravalle,  N. Pimpinelli,  M. Caproni, 
  • Pages: e417-e419
  • First Published: 08 February 2022

‘COVID nose’ – A unique post–COVID pigmentary sequelae reminiscing Chik sign: A descriptive case series

A. Sil,  A. Panigrahi,  A. Chandra,  J.D. Pramanik, 
  • Pages: e419-e421
  • First Published: 08 February 2022

Development of eruptive pseudoangiomatosis following immunization with COVISHIELD vaccine in an adult

T. Prarthana,  S. Bakshi,  V. Hanumanthu,  U. Nahar,  D. De, 
  • Pages: e421-e423
  • First Published: 08 February 2022

Reply to “COVID vaccine–induced lichen planus on areas previously affected by vitiligo”

E. Bularca,  J. Monte-Serrano,  P. Villagrasa-Boli,  A. Lapeña-Casado,  S. de-la-Fuente, 
  • Pages: e423-e425
  • First Published: 11 February 2022

Reply to “Dermatoses caused by face mask wearing during the COVID-19 pandemic”

F. Bardazzi,  L. Sacchelli,  C. Loi,  F. Filippi,  A. Guglielmo, 
  • Pages: e425-e427
  • First Published: 17 February 2022

A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccine

S. Ohmura,  S. Hanai,  R. Ishihara,  Y. Ohkubo,  T. Miyamoto, 
  • Pages: e427-e429
  • First Published: 17 February 2022

Unilateral linear purpuric rash heralding SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia

Y.-T. Hung,  Y.-L. Huang,  Y.-Y. Chang,  W.-T. Chen, 
  • Pages: e429-e431
  • First Published: 17 February 2022

Pityriasis lichenoides et varioliformis acuta after SARS-CoV-2 infection and relapse after vaccination

T. Mäkilä,  L. Jeskanen,  M. Butina,  L. Harjama,  A. Ranki,  T. Mälkönen,  N. Kluger, 
  • Pages: e431-e433
  • First Published: 19 February 2022

Reply to ‘The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?’ by Damiani G et al.

G. Avallone,  S. Giordano,  C. Astrua,  M. Merli,  R. Senetta,  C. Conforti,  S. Ribero,  A.V. Marzano,  P. Quaglino, 
  • Pages: e433-e435
  • First Published: 23 January 2022

LETTERS TO THE EDITOR

The spectrum of skin disease in VEXAS syndrome: a report of a novel clinico-histopathologic presentation

T. Khosravi-Hafshejani,  M. O’Connor,  F. To,  G. Sreenivasan,  K. Shojania,  S. Au, 
  • Pages: e435-e437
  • First Published: 13 January 2022

The watch sign: an atypical clinical finding of frontal fibrosing alopecia in two male patients

T. de M. Barreto,  R. F. Cortez de Almeida,  P. Müller Ramos,  T. Jeunon,  D. F. Melo, 
  • Pages: e437-e439
  • First Published: 16 January 2022

Skin biopsy is helpful in the diagnosis of hereditary fibrosing POIKiloderma with tendon contractures, myopathy and pulmonary fibrosis, due to FAM111B mutation

S. Leclerc-Mercier,  S. Mercier,  N. Bellon,  S. Hadj-Rabia,  C. Bodemer,  P. Hoeger,  S. Barbarot,  S. Fraitag, 
  • Pages: e439-e441
  • First Published: 16 January 2022

Crisaborole: an emerging therapy for prurigo pigmentosa

M. Xu,  N. Wu,  Q. Du,  Z. Zhou,  D. Deng,  Y. Liu, 
  • Pages: e441-e443
  • First Published: 17 January 2022

Maintenance of clinical response after short treatment with cemiplimab for advanced squamous cell carcinoma

C. Conforti,  L. Toffoli,  M. Agozzino,  D. Fedele,  S. Moroso,  N. di Meo,  I. Zalaudek, 
  • Pages: e443-e445
  • First Published: 17 January 2022

Successful treatment of eruptive keratoacanthomas with actitretin for patients on checkpoint inhibitor immunotherapy

R.J. Schwartz,  G. Ho,  A. Smith,  H. Collgros,  A. Regio Pereira,  B. Gouveia,  G.V. Long,  A.M. Menzies,  A.J. Potter,  E. Paver,  P. Star,  R.A. Scolyer,  L.K. Martin, 
  • Pages: e445-e448
  • First Published: 18 January 2022

Comorbid palmoplantar keratoderma type 1A and Loeys-Dietz syndrome type 3 in a patient with a chromosome 15 microdeletion

D. Mintoff,  N.P Pace,  B. Al-Kawlani,  P. Bauer,  I. Borg, 
  • Pages: e448-e451
  • First Published: 21 January 2022

Impact of childhood atopic dermatitis on life decisions for caregivers and families

K. Capozza,  A. Schwartz,  J.E. Lang,  J. Chalmers,  J. Camilo,  K. Abuabara,  K. Kelley,  J. Harrison,  A. Vastrup,  L. Stancavich,  A. Tai,  A.B. Kimball,  A.Y. Finlay, 
  • Pages: e451-e454
  • First Published: 20 January 2022

Family history of psoriasis: a novel protective factor for therapy switch in patients treated with Secukinumab or Ixekizumab

F. Manzo Margiotta,  A. Michelucci,  S. Panduri,  A. Tonini,  G. Davini,  M. Romanelli,  R. Morganti,  V. Dini, 
  • Pages: e454-e456
  • First Published: 19 January 2022

Novel splice mutation in CDSN gene causing type b peeling skin syndrome

I. Navarro-Navarro,  D. Jiménez-Gallo,  R. de la Varga-Martínez,  I. Villegas-Romero,  F. Mora-López,  M. Linares-Barrios,  L. Youssefian,  H. Vahidnezhad,  J. Uitto, 
  • Pages: e456-e460
  • First Published: 23 January 2022

Duration of acceptable delay between the time of diagnosis and treatment of melanoma, cutaneous squamous cell carcinoma and basal cell carcinoma

M. Alam,  J.R. Etzkorn,  J.G. Albertini,  J.S. Bordeaux,  M.L. Council,  I.A. Maher,  K.S. Nehal,  D.G. Brodland,  A.F. Haas,  B.Y. Kang,  S.A. Ibrahim,  R.E. Christensen,  E. Poon,  B. Worley, 
  • Pages: e460-e464
  • First Published: 23 January 2022

Successful treatment of psoriasis with adalimumab induced no changes in the gut microbiota

T. Todberg,  A. Egeberg,  C. Zachariae,  N. Sørensen,  O. Pedersen,  L. Skov, 
  • Pages: e464-e467
  • First Published: 24 January 2022

Burden of treatment in adult patients with atopic dermatitis

E. Nic Dhonncha,  C. O'Connor,  N. Cosgrave,  M. Murphy, 
  • Pages: e467-e468
  • First Published: 24 January 2022

Tirbanibulin 1% ointment as a potential novel treatment for anogenital warts

S. Braasch,  P.A. Gerber,  S.A. Braun, 
  • Pages: e468-e470
  • First Published: 23 January 2022

Frontal fibrosing alopecia in breast cancer patients on aromatase-inhibitor: 2 cases

A. Murad,  A. Wolinska,  W.F. Bergfeld, 
  • Pages: e470-e472
  • First Published: 23 January 2022

Skin of colour and psychodermatology: a quantitative analysis of common cutaneous conditions and psychocutaneous disorders

V.A. Jones,  S. Folarin,  K. França, 
  • Pages: e472-e473
  • First Published: 24 January 2022

Sexually transmitted co-infections in men who have sex with men diagnosed with primary or secondary syphilis

D. Richardson,  J. Devlin,  H. Smith,  K. Parashar,  C. Fitzpatrick,  D. Williams, 
  • Pages: e474-e475
  • First Published: 24 January 2022

Prognostic factors for treatment failure of imiquimod treatment in basal cell carcinoma – an observational study

B.J.A. Verkouteren,  L.C.F. Oostewechel,  P.J. Nelemans,  K.A.E. Sinx,  A.H.M.M. Arits,  A.I.P. Vernemmen,  V.J.L. Winnepenninckx,  N.W.J. Kelleners-Smeets,  K. Mosterd, 
  • Pages: e475-e477
  • First Published: 24 January 2022

Treatment of children from 6 to 11 years old affected by moderate–severe atopic dermatitis with dupilumab: a first perspective from a single-center real-life experience in Italy

C. Colonna,  M. Zussino,  N.A. Monzani,  A. Ponziani,  R. Cavalli, 
  • Pages: e478-e480
  • First Published: 23 January 2022

Basic skin therapy effects on skin inflammation and microbiome composition in patients with atopic dermatitis after challenges with grass pollen

A. Heratizadeh,  L.M. Roesner,  S. Traidl,  L. Moitinho-Silva,  B. Ellinghusen,  E. Rodriguez,  I. Harder,  M. Sapak,  S. Weidinger,  P. Badorrek,  J.M. Hohlfeld,  T. Werfel, 
  • Pages: e480-e483
  • First Published: 24 January 2022

Mosaic GNA11 mutations and a second hit in KRAS in phakomatosis pigmentovascularis are associated with intraosseous arteriovenous malformations in the jaw

Y. Sun,  L. Su,  Y. Rao,  Z. Wang,  D. Wang,  X. Fan,  R. Cai(蔡韧), 
  • Pages: e484-e486
  • First Published: 26 January 2022

Improvement of chronic nodular prurigo with baricitinib

M.P. Pereira,  C. Zeidler,  S. Ständer, 
  • Pages: e486-e488
  • First Published: 09 February 2022

Cavitary pulmonary tuberculosis during treatment with guselkumab

A. Cerejeira,  G. Canelas,  J. Vide,  R. Duro,  F. Azevedo,  S. Magina, 
  • Pages: e488-e490
  • First Published: 09 February 2022

Impressive response to four cemiplimab cycles of a sonidegib-resistant giant basosquamous carcinoma of the midface

T. Gambichler,  I. Stricker,  M. Neid,  A. Tannapfel,  L. Susok, 
  • Pages: e490-e492
  • First Published: 10 February 2022

Serial dermoscopic monitoring of subungual scabies mites in an infant with crusted scabies

Y. Jiang,  A.-T. Zhan,  F. Qiu,  Y.-M. Fan, 
  • Pages: e492-e494
  • First Published: 10 February 2022

Dystrophic calcinosis of the scalp from artificial hair implants: treatment with sodium metabisulfite

E. Casañas Quintana,  W. Kempf,  R.M. Trüeb, 
  • Pages: e494-e496
  • First Published: 10 February 2022